Ex Parte BloomDownload PDFBoard of Patent Appeals and InterferencesMar 24, 200810428146 (B.P.A.I. Mar. 24, 2008) Copy Citation UNITED STATES PATENT AND TRADEMARK OFFICE ____________ BEFORE THE BOARD OF PATENT APPEALS AND INTERFERENCES ____________ Ex parte PAUL D. BLOOM ____________ Appeal 2008-0963 Application 10/428,146 Technology Center 1700 ____________ Decided: March 24, 2008 ____________ Before EDWARD C. KIMLIN, BRADLEY R. GARRIS, and CHARLES F. WARREN, Administrative Patent Judges. GARRIS, Administrative Patent Judge. DECISION ON APPEAL Appellant appeals under 35 U.S.C. § 134 from the Examiner’s decision rejecting claims 1-56. We have jurisdiction under 35 U.S.C. § 6. We REVERSE. Appeal 2008-0963 Application 10/428,146 Appellant claims a composition comprising a triacylglycerol oil (e.g., a heat polymerized triacylglycerol oil) which has been hydrogenated and which has carbon-carbon bonds between triacylglycerol units of the oil (claim 1). Representative claim 1 reads as follows: 1. A composition comprising a hydrogenated heat polymerized triacylglycerol oil, said hydrogenated heat polymerized triacylglycerol oil having carbon-carbon bonds between triacylglycerol units of said oil. The references set forth below are relied upon by the Examiner as evidence of unpatentability. Morgan 2,519,492 Aug. 22, 1950 Kodali 6,291,409 B1 Sep. 18, 2001 Claims 1, 5-9, 37-41, and 49-56 are rejected under 35 U.S.C. § 102(b) as being anticipated by Morgan. Claims 2-4 and 29-35 are rejected under 35 U.S.C. § 102(b) as anticipated by, or alternatively under 35 U.S.C. § 103(a) as being unpatentable over Morgan. Claims 42-48 are rejected under 35 U.S.C. § 103(a) as being unpatentable over, Morgan. Claims 1-49 are rejected under 35 U.S.C. § 102(b) as being anticipated by Kodali. Claims 50-56 are rejected under 35 U.S.C. § 103(a) as being unpatentable over Kodali in view of Morgan. The above-noted rejections cannot be sustained for the reasons expressed below. 2 Appeal 2008-0963 Application 10/428,146 The Rejections based on Morgan As correctly argued by Appellant (App. Br. 15-38; Reply Br. 7-9), the hydrogenated alkyd resins of Morgan do not anticipate the hydrogenated triacylglycerol oil having carbon-carbon bonds between triacylglycerol units required by the rejected claims. The Examiner attempts to rebut this argument as follows: Appellants [sic] … continue to insist that the prior art, Morgan, does not possess the triacylglycerol structure as claimed in view of page 16 of the Appeal Brief. However, appellants [sic] fail to recognize that "triacyl" means three "acyl" units and each "acyl" unit is represented by the structure as shown in the following table. The structure of "glycerol" is also shown in the table. As shown in the table, the structure disclosed in Morgan clearly possesses the triacylglycerol structure as claimed. (Ans. 17.) This rebuttal is unpersuasive. Appellant has correctly explained that, during examination proceedings, claims should be given their broadest reasonable interpretation consistent with the Specification and should be read in light of the Specification as they would be 3 Appeal 2008-0963 Application 10/428,146 interpreted by one of ordinary skill in the art (Reply Br. 3). In re Am. Acad. Of Sci. Tech Ctr., 367 F.3d 1359, 1364 (Fed. Cir. 2004). The Examiner has provided no support whatsoever for the above-quoted proposition that the rejected claims would be interpreted by an artisan consistent with Appellant’s Specification to include the hydrogenated alkyd resin structure of Morgan. On the other hand, Appellant has presented substantial argument and evidence that the Examiner’s claim interpretation is improper (Reply Br. 4-9). Significantly, this argument and evidence have not been specifically addressed by the Examiner. Under these circumstances, we find that Morgan does not anticipate the so-rejected claims. Moreover, this deficiency is not supplied in the § 103 rejections since the Examiner’s obviousness analysis does not address the flaw of the § 102 rejection. Therefore, we cannot sustain either the § 102 or the § 103 rejections based on Morgan. The Rejections based on Kodali All of the rejected claims require carbon-carbon bonds between triacylglycerol units. According to the Examiner, “the cyclo- propanation process of Kodali does not remove all the triacylglycerol units," and therefore “the Examiner has a reasonable basis that the resins of Kodali … inherently possess the carbon-carbon bonds between triacylglycerol units as claimed when crosslinked or oxidized” (Ans. para. bridging 15-16). We cannot agree with the Examiner’s inherency position. 4 Appeal 2008-0963 Application 10/428,146 We understand that Kodali’s cyclopropanation process yields a product which may often include a number of triacylglycerols that have not been cyclopropanated (col. 3, ll. 31-42). However, in the absence of appropriate polymerization or crosslinking, such a product will not contain the required carbon-carbon bonds, and there is no teaching or suggestion in Kodali of polymerizing or crosslinking patentee’s product. To the contrary, Kodali’s cyclopropanation method decreases a propensity of the fatty acyl group towards oxidation and/or polymerization (col. 12, ll. 43-45). The Examiner’s inherency position may be based on the possibility that crosslinking of Kodali’s product could occur thereby yielding the carbon-carbon bonds under consideration. However, such a possibility is inadequate to establish inherency as Appellant has correctly explained (App. Br. 42). To establish inherency, the evidence must make clear that the missing descriptive matter is necessarily present in the prior art. In re Robertson, 169 F.3d 743, 745 (Fed. Cir. 1999). Inherency may not be established by probabilities or possibilities, and therefore the mere fact that a certain thing may result from a given set of circumstances is not sufficient. Id. For these reasons, we cannot the § 102 rejection of claims 1-49 as being anticipated by Kodali. Furthermore, since the infirmity of this rejection is not cured or even addressed by the Examiner’s obviousness position, we also cannot sustain the § 103 rejection of claims 50-56 as being unpatentable over Kodali in view of Morgan. 5 Appeal 2008-0963 Application 10/428,146 CONCLUSION The decision of the Examiner is reversed. REVERSED cam STERNE, KESSLER, GOLDSTEIN & FOX P.L.L.C. 1100 NEW YORK AVENUE, N.W. WASHINGTON DC 20005 6 Copy with citationCopy as parenthetical citation